Financial statements Mp Pharma
Balance sheet data of MP PHARMA
Year
|
2018
|
2019
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 1 497 607,33 | 1 222 417,81 | 1 662 943,68 | 1 589 111,23 | 1 667 819,41 |
A. Fixed assets | 141 373,67 | 1 114 282,67 | 1 653 472,50 | 1 567 037,50 | 749 872,82 |
B. Current assets | 1 351 233,66 | 104 460,30 | 9 471,18 | 22 073,73 | 917 946,59 |
C. Share capital contributions (basic funds) | 5 000,00 | 3 674,84 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 1 497 607,33 | 1 222 417,81 | 1 662 943,68 | 1 589 111,23 | 1 667 819,41 |
A. Equity | 1 254 561,02 | 1 126 591,23 | 19 127,73 | -49 058,01 | 27 801,49 |
B. Liabilities and provisions for liabilities | 243 046,31 | 95 826,58 | 1 643 815,95 | 1 638 169,24 | 1 640 017,92 |
I. Long-term liabilities | 0,00 | 0,00 | 1 600 000,00 | 1 600 000,00 | 1 600 000,00 |
II. Short-term liabilities | 243 046,31 | 95 826,58 | 43 815,95 | 38 169,24 | 40 017,92 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.